Richard Longnecker Selected Research

Member 14 Tumor Necrosis Factor Receptors

12/2020	Herpesvirus Entry Mediator Binding Partners Mediate Immunopathogenesis of Ocular Herpes Simplex Virus 1 Infection.
1/2019	Characterization of Sex Differences in Ocular Herpes Simplex Virus 1 Infection and Herpes Stromal Keratitis Pathogenesis of Wild-Type and Herpesvirus Entry Mediator Knockout Mice.
1/2019	Erratum for Riccio et al., "Characterization of Sex Differences in Ocular Herpes Simplex Virus 1 Infection and Herpes Stromal Keratitis Pathogenesis of Wild-Type and Herpesvirus Entry Mediator Knockout Mice".
1/2017	Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.
10/2015	Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner.
10/2011	Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Longnecker Research Topics

Disease

30	Infections 01/2021 - 02/2002
13	Neoplasms (Cancer) 10/2020 - 02/2002
9	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2022 - 11/2003
8	Lymphoma (Lymphomas) 01/2019 - 03/2009
5	Epstein-Barr Virus Infections 08/2014 - 12/2002
4	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 01/2015
4	Herpetic Keratitis 12/2020 - 10/2015
4	Latent Infection 12/2017 - 02/2002
3	Splenomegaly 01/2018 - 04/2011
3	Hodgkin Disease (Hodgkin's Disease) 05/2012 - 12/2003
3	Carcinogenesis 09/2007 - 02/2002
2	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 01/2017
2	Keratitis 01/2019 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2011
2	Vesicular Stomatitis 01/2013 - 02/2009
2	HIV Infections (HIV Infection) 12/2002 - 02/2002
1	Viral Encephalitis 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2017
1	Herpes Simplex 05/2017
1	Neuroblastoma 01/2017
1	Herpesviridae Infections (Herpesvirus Infection) 01/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2016
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 05/2007
1	Nasopharyngeal Carcinoma 03/2006
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 05/2005
1	Carcinoma (Carcinomatosis) 02/2004
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2002

Drug/Important Bio-Agent (IBA)

18	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 02/2002
12	Glycoproteins (Glycoprotein)IBA 01/2019 - 02/2002
6	Member 14 Tumor Necrosis Factor ReceptorsIBA 12/2020 - 10/2011
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2005
4	Interferon Type IIBA 01/2022 - 01/2015
3	NectinsIBA 07/2012 - 10/2011
2	CholesterolIBA 11/2017 - 11/2003
2	Viral ProteinsIBA 01/2017 - 11/2004
2	Monoclonal AntibodiesIBA 05/2016 - 07/2003
2	Peptides (Polypeptides)IBA 07/2009 - 09/2007
1	InflammasomesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	LigandsIBA 01/2021
1	E2F1 Transcription FactorIBA 10/2020
1	Cyclin D3IBA 10/2020
1	Interferon-betaIBA 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2020
1	Ephrin-A2 (Ephrin A2)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	TAK-659IBA 01/2018
1	Syk KinaseIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 11/2017
1	Virus ReceptorsIBA 01/2017
1	Single-Chain AntibodiesIBA 01/2017
1	dinutuximabIBA 01/2017
1	VaccinesIBA 11/2016
1	ibrutinibIBA 05/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 05/2016
1	Phosphotransferases (Kinase)IBA 12/2015
1	Dasatinib (BMS 354825)FDA Link 07/2012
1	Sirolimus (Rapamycin)FDA Link 04/2011
1	Immunoglobulins (Immunoglobulin)IBA 03/2010
1	Tyrosine (L-Tyrosine)FDA Link 03/2009
1	Pharmaceutical PreparationsIBA 03/2006
1	Messenger RNA (mRNA)IBA 05/2005
1	AntigensIBA 05/2004
1	Serine (L-Serine)FDA Link 02/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2004
1	methyl-beta-cyclodextrinIBA 11/2003
1	LipidsIBA 11/2003
1	Nystatin (Mycostatin)FDA LinkGeneric 11/2003
1	Viral AntigensIBA 09/2003
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 02/2002
1	Histocompatibility Antigens Class IIIBA 02/2002

Therapy/Procedure

6	Therapeutics 01/2021 - 02/2002
2	Organ Transplantation 12/2002 - 02/2002
1	Immunomodulation 01/2017
1	Transplantation 05/2016
1	Lenses 05/2012